Concepedia

Teiichiro Koga

TK

13

Publications

783

Citations

12

H-Index

1987

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Biomedical Research Laboratories (United States)

University of California, San Francisco

Teiichiro Koga is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1987–2006

13

Publications

13

Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy

Carl Friddle, Teiichiro Koga, Edward M. Rubin et al. · Proceedings of the National Academy of Sciences · 2000 · 202 citations

, , +17

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

Ichiro Watanabe, Aiko Tomita, Miho Shimizu et al. · Clinical Pharmacology & Therapeutics · 2003 · 173 citations

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

Teiichiro Koga, Yohko Shimada, Masao Kuroda et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1990 · 168 citations

, , +8

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

Toru Komai, Eiji Shigehara, Taro Tokui et al. · Biochemical Pharmacology · 1992 · 65 citations

, , +6

Epi-cochlioquinone A, a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor Produced by Stachybotrys bisbyi.

Tomoyuki Fujioka, Keiko Yao, KIYOSHI HAMANO et al. · The Journal of Antibiotics · 1996 · 41 citations · Full text

Rows per page

1–5 of 13